Skip to main content
OpenTrials
Completed

NCT Number: NCT04561193

Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19)

Multicenter retrospective chart review of patients admitted to any of the four Methodist Health System hospitals

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Methodist Dallas Medical Center

Dallas, Texas, 75203, United States

About this study

Multicenter retrospective chart review of patients admitted to any of the four Methodist Health System hospitals (Methodist Richardson, Methodist Mansfield, Methodist Charlton, or Methodist Dallas) between February 1 and April 30, 2020. All study center utilize Epic ® electronic health record (Verona, Wisconsin; www.epic.com) for which all data will be extracted from.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients admitted to Methodist Richardson, Methodist Mansfield, Methodist Charlton, or Methodist Dallas Medical Centers between February 1, 2020 and April 30, 2020
  • >18 years old
  • Positive SARS-CoV-2 (COVID-19) PCR test

Exclusion criteria

  • Outpatient or emergency department visit
  • Not admitted to an inpatient or observation status for >24 hours

Treatment and study plan

Observational

Other

Observational

Primary outcomes

  1. Prevalence of subsequent and co-infections

    Time frame: Feb 2020 - April 2020

    Prevalence of subsequent and co-infections

Secondary outcomes

  1. In-hospital mortality

    Time frame: Feb 2020 - April 2020

    In-hospital mortality

  2. Hospital length of stay (LOS)

    Time frame: Feb 2020 - April 2020

    Hospital length of stay (LOS)

Sponsors and collaborators

Lead sponsor

Methodist Health System

Other

Registry information

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Sep 23, 2020
Registry last updated
Mar 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.